Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02787434 · ClinicalTrials.gov registry record · NA
Addressing Prostate Cancer Information Disparities With eHealth Technology
A NA study of Prostate Neoplasm, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 2
- Study locations
NCT02787434: Completed NA study of Prostate Neoplasm, sponsored by Tufts University.
NCT02787434 is a NA study of Prostate Neoplasm that has completed, run by Tufts University. The registered enrollment target is 125 participants, below the 1,116-participant average among 9 other Prostate Neoplasm trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02787434, a NA study of Prostate Neoplasm, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that will empower them to take part in decision-making regarding prostate cancer screening (PCS). The Prostate Cancer Screening Preparation (PCSPrep) tool was designed with intend to be delivered in primary care settings with attention to patient/provider interaction. Funding for this study comes from the National Institute of Health/National Cancer Institute (1R21CA178296).
Primary Outcome
Confidence in ones ability to gather requisite information and to make an informed decision
Conditions Studied
Interventions
- OTHER Prostate Cancer Screening Decision Aid
Study Locations (2)
Massachusetts
- Tufts University - Medford
Virginia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02787434 record still lists
NCT02787434 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,116-participant average among 9 other Prostate Neoplasm trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Prostate Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Prostate Cancer Screening Decision Aid is the first listed.
NCT02787434 reports a single indexed study location in Massachusetts, Virginia.
Frequently Asked Questions
What is clinical trial NCT02787434 about?
NCT02787434 is a clinical study titled "Addressing Prostate Cancer Information Disparities With eHealth Technology". This is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that will empower them to take part in decision-making regarding prostate cancer screening (PCS). The Prostate Cancer S...
What is the current status of trial NCT02787434?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2014-08. Estimated completion is 2016-10.
What conditions does trial NCT02787434 study?
This clinical trial studies the following conditions: Prostate Neoplasm.
What interventions are being tested in trial NCT02787434?
The interventions under investigation include: Prostate Cancer Screening Decision Aid (OTHER).
Who is sponsoring clinical trial NCT02787434?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02787434 being conducted?
This trial has 2 study locations across Massachusetts, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02787434's enrollment target sits among peer trials
125 6th of 9 higher than 4 of 9 other Prostate Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
RECRUITING · NA
-
CyberKnife Dose Escalation Prostate Cancer Trial
ACTIVE NOT RECRUITING · NA
-
Health Gatherings - For Your Health After Cancer
COMPLETED · NA
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
-
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RECRUITING
-
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia